One of the key goals of the Centre of Excellence in Cellular Immunotherapy (CoE CIT) is to facilitate the increase in cellular immunotherapy clinical trial activity. As such, the CoE CIT’s Pilot Clinical Trial Development Program was established as an accelerator program to facilitate early phase investigator initiated and collaborative clinical trials. We do this by providing support and expertise to co-develop and manufacture innovative, cell-based immunotherapy concepts with our partners for rapid translation into pilot clinical trials with potential for commercial outcomes.
CoE CIT Pilot Clinical Trial Program Application Process
Acceptance into the CoE CIT Pilot Clinical Trial Development Program is based on an application process. Our Clinical and Scientific Advisory Committee (CSAC) will review your application and, if successful, the CoE CIT team, in collaboration with our legal and commercial teams, will negotiate and execute a commercial agreement.
CoE CIT application
Download the CoE CIT application here
Frequently asked questions
Contact
For more information contact